Hot Pursuit     04-Jul-24
Dr Reddys Laboratories Ltd spurts 1.14%, up for third straight session
Dr Reddys Laboratories Ltd is quoting at Rs 6498.95, up 1.14% on the day as on 12:49 IST on the NSE. The stock is up 25.5% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

Dr Reddys Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs 6498.95, up 1.14% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.28% on the day, quoting at 24354.6. The Sensex is at 80227.97, up 0.3%. Dr Reddys Laboratories Ltd has added around 11.59% in last one month.

Meanwhile, Nifty Pharma index of which Dr Reddys Laboratories Ltd is a constituent, has added around 4.63% in last one month and is currently quoting at 19915.3, up 1.3% on the day. The volume in the stock stood at 1.64 lakh shares today, compared to the daily average of 6.23 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 6499.9, up 1.31% on the day. Dr Reddys Laboratories Ltd is up 25.5% in last one year as compared to a 25.55% gain in NIFTY and a 46.49% gain in the Nifty Pharma index.

The PE of the stock is 24.7 based on TTM earnings ending March 24.

Previous News
  Dr Reddys Laboratories Ltd slips for fifth straight session
 ( Hot Pursuit - 02-Jul-25   13:35 )
  Dr Reddys Laboratories to hold board meeting
 ( Corporate News - 24-Jun-25   09:53 )
  Dr Reddys Laboratories allots 10,685 equity shares under ESOP
 ( Corporate News - 23-Jun-25   18:31 )
  Dr Reddys Laboratories allots Equity shares
 ( Corporate News - 16-Jun-25   10:27 )
  Dr Reddys Laboratories Ltd up for third consecutive session
 ( Hot Pursuit - 12-Jun-25   13:05 )
  Dr Reddys Laboratories Ltd soars 0.07%, up for fifth straight session
 ( Hot Pursuit - 09-Jun-25   13:00 )
  Dr Reddys Lab gains on global biosimilar deal with Alvotech
 ( Hot Pursuit - 05-Jun-25   10:10 )
  Alvotech and Dr Reddy's enter into collaboration and license agreement for pembrolizumab
 ( Corporate News - 05-Jun-25   09:20 )
  Dr Reddys Laboratories allots 57,840 equity shares under ESOS
 ( Corporate News - 03-Jun-25   16:28 )
  Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA
 ( Hot Pursuit - 26-May-25   09:33 )
  DRL’s USA facility gets 2 observations from USFDA
 ( Hot Pursuit - 19-May-25   08:32 )
Other Stories
  V2 Retail’s revenue climbs 51% YoY in Q1 FY26
  03-Jul-25   15:14
  Arkade Developers surges after acquiring Goregaon-based redevelopment project
  03-Jul-25   15:07
  VST Industries Ltd leads losers in 'A' group
  03-Jul-25   15:00
  CARE Ratings reaffirms ratings of India Shelter Finance at 'CARE AA-' with 'stable’' outlook
  03-Jul-25   14:56
  U. Y. Fincorp Ltd leads losers in 'B' group
  03-Jul-25   14:45
  Bajel Projects hits the roof after securing mega order from Power Grid Corporation
  03-Jul-25   14:41
  Volumes soar at DCM Shriram Ltd counter
  03-Jul-25   14:30
  REC Ltd down for fifth straight session
  03-Jul-25   13:35
  Persistent Systems appoints Shimona Chadha as CMO
  03-Jul-25   13:19
  Maruti Suzuki India Ltd gains for third straight session
  03-Jul-25   13:05
Back Top